semaglutide warnings Patients taking semaglutide, including Wegovy and Ozempic, have been issued a warning Check our link in bio for full story #surrey #surreylive #surreynews FDA Ozempic Warning | Ozempic

Description

I had the pleasure of discussing our approach to helping patients achieve a healthy weight working with Marathon Health providers and teams

Night sweats in women are one of the most common symptoms of menopause, affecting up to four out of five menopausal women.

To jab or not to jab: Complicated questions of injections.

The first phase 3 retatrutide trial, TRIUMPH-4, top-line data announced today Retatrutide, a triple GLP-1,GIP, glucagon agonist studied in patients with obesity and osteoarthritis 28.7% weight loss at 68 weeks Reduced key cardiometabolic risk markers non-HDL cholesterol, triglycerides, and hsCRP Highest dose lowered systolic BP by 14 mmHg Reduced WOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function GI side effects most common adverse event We now await 7 additional phase 3 trials in other obesity related comorbidities